DELIVERY ORDER

INTERNATIONAL BUSINESS MACHINES CORPORATION - CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER), BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE: DEVELOPMENT OF NEW AND INNOVATIVE METHODS FOR AUTOMATED REPORTING FOR CBER-REGULATED BIOLOGIC

PIID: 75F40122F19004
Effective Date: Sep 27, 2022End Date: Closed on Sep 26, 2024

Key Details

Dollars Obligated
$8.2M
Awarding Sub-Agency
Food and Drug Administration
NAICS Code
518210
Parent IDIQ (PIID)
75F40118D10053
Place of Performance
MD

Description

CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER), BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE: DEVELOPMENT OF NEW AND INNOVATIVE METHODS FOR AUTOMATED REPORTING FOR CBER-REGULATED BIOLOGIC

Context & Analysis

Department of Health and Human Services obligated $8,234,421.12 to INTERNATIONAL BUSINESS MACHINES CORPORATION for center for biologics evaluation and research (cber), biologics effectiveness and safety (best) initiative: development of new and innovative methods for automated reporting for cber-regulated biologic. The award is classified under NAICS 518210 and issued as a delivery order contract. Performance is located in MD. This award is one of several similar procurements from Department of Health and Human Services under NAICS 518210 — related awards are listed below.

Contractor Information

UEI: VV9KH3L99VE3

Stay Updated

Get notified about new opportunities matching your interests.

Related